Imaging test for brain tumor diagnosis
Part of Cancer clinical trials.
This trial tests a special PET scan tracer (18F-FET) to see if it can help doctors better identify and plan treatment for brain tumors. It may be an option if you are scheduled for surgery for a suspected new glioma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 20 years or older.
- You must have a suspected glioma and be scheduled for surgery.
- You must be alert and able to give your own consent.
- You cannot have serious liver or kidney problems in the last 6 months.
- You cannot be allergic to radiopharmaceuticals or contrast agents.
- You must not be pregnant, breastfeeding, or planning pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests how well a special PET-MRI scan (using a radioactive tracer) can find and measure low-grade brain tumors. It may help doctors better track these tumors while you start or continue treatment.
This study checks how well an FDOPA PET scan can identify and describe a specific type of brain tumor at the beginning. Results may help doctors decide on the best next steps for diagnosis and treatment planning.
This study uses special scans (PET and MRI) to look at brain tumors in more detail. It aims to understand tumor metabolism and oxygen levels, which may help guide treatment.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This early-phase study uses a special PET scan plus MRI to help doctors tell apart tumor changes in children with aggressive gliomas. It may help find whether treatment is working or if the tumor is progressing, while also mapping tumor activity in the brain.
This trial tests a new kind of PET scan that uses a special tracer (Zr-89 crefmirlimab berdoxam) to help doctors see brain tumors more clearly before surgery. If you are scheduled to have your brain tumor removed, this scan may give your surgeon extra information to guide the operation.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.